Education
About Us
Working with TipRanks
Follow Us
Ontrak (OTRK)
NASDAQ:OTRK
OTRK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.27 - $7.58
Previous CloseN/A
Volume226.92K
Average Volume (3M)12.70K
Market Cap
$6.62M
Enterprise Value$10.88M
Total Cash (Recent Filing)$1.89M
Total Debt (Recent Filing)$9.48M
Price to Earnings (P/E)―
Beta0.99
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.35
Shares Outstanding4,217,846
10 Day Avg. Volume15,942
30 Day Avg. Volume12,701
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.58
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.64
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.59
Enterprise Value/Ebitda-0.67
Forecast
1Y Price Target
$4.00Price Target Upside173.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
Ontrak News
PremiumCompany Announcements
Ontrak, Inc. Earnings Call: Balancing Growth and Challenges
PremiumCompany Announcements
Ontrak, Inc. Reports 2024 Financial Results and Strategic Partnerships
PremiumCompany Announcements
Ontrak Delays Yearly Report Filing---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OTRK FAQ
What was Ontrak’s price range in the past 12 months?
Ontrak lowest stock price was $1.27 and its highest was $7.58 in the past 12 months.
What is Ontrak’s market cap?
Ontrak’s market cap is $6.62M.
When is Ontrak’s upcoming earnings report date?
Ontrak’s upcoming earnings report date is Aug 06, 2025 which is in 102 days.
How were Ontrak’s earnings last quarter?
Ontrak released its earnings results on Apr 14, 2025. The company reported -$1.35 earnings per share for the quarter, missing the consensus estimate of -$1.24 by -$0.11.
Is Ontrak overvalued?
According to Wall Street analysts Ontrak’s price is currently Undervalued.
Does Ontrak pay dividends?
Ontrak does not currently pay dividends.
What is Ontrak’s EPS estimate?
Ontrak’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ontrak have?
Ontrak has 4,217,846 shares outstanding.
What happened to Ontrak’s price movement after its last earnings report?
Ontrak reported an EPS of -$1.35 in its last earnings report, missing expectations of -$1.24. Following the earnings report the stock price went down -9.639%.
Which hedge fund is a major shareholder of Ontrak?
Currently, no hedge funds are holding shares in OTRK
---
Company Description
Ontrak
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.
---
OTRK Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced outlook with significant new customer acquisitions and a strong sales pipeline but was offset by notable challenges, including revenue decline due to customer loss, decreased gross margins, increased disenrollment rates, and negative cash flow, leading to a neutral sentiment.Read More>---
OTRK Stock 12 Month Forecast
Average Price Target
$4.00
▲(173.97% Upside)
Technical Analysis
Phio Pharmaceuticals
―
GT Biopharma
―
AEON Biopharma
―
Dermata Therapeutics
―
Lipella Pharmaceuticals, Inc.
―
Best Analysts Covering OTRK
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-59.05%
reiterated a buy rating 5 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -59.05% per trade.
---